Atypical posterior reversible encephalopathy syndrome associated with Lenvatinib therapy in a patient with metastatic thyroid cancer—A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Atypical posterior reversible encephalopathy syndrome associated with Lenvatinib therapy in a patient with metastatic thyroid cancer—A case report

Published:2022-03-03 Issue:9 Volume:5 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Abhishek Mahajan¹^ORCID,Renuka Ashtekar¹,Ujjwal Agarwal¹,Amit Choudhari¹,Vijay Patil²,Vanita Noronha²,Nandini Menon²^ORCID,Kumar Prabash²

Affiliation:

1. Department of Radiodiagnosis and Imaging Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute Mumbai Maharashtra India

2. Department of Medical Oncology Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute Mumbai Maharashtra India

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1605

Reference7 articles.

1. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions

2. Posterior reversible encephalopathy syndrome—Insight into pathogenesis, clinical variants and treatment approaches

3. Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy Syndrome

4. Posterior Reversible Encephalopathy Syndrome: A Truly Treatable Neurologic Illness

5. Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib;Stjepanovic N;Biol Theory,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Review of the Imaging Recommendations for Diagnosis, Staging, and Management of Thyroid Carcinoma;Journal of Clinical Medicine;2024-05-14

2. Posterior Reversible Encephalopathy Syndrome as an Adverse Effect of Lenvatinib in a Patient with Papillary Thyroid Carcinoma: A Case Report;International Journal of Endocrinology and Metabolism;2023-07-29

3. Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma;Brain Sciences;2022-12-23

4. Effect of the m6ARNA gene on the prognosis of thyroid cancer, immune infiltration, and promising immunotherapy;Frontiers in Immunology;2022-11-01

5. Carboplatin/lenvatinib/paclitaxel;Reactions Weekly;2022-10-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3